ArticleOncology research2026

miR-100-5p Enhances Cell Cycle-Mediated Chemoresistance by Modulating the CTDSPL/pRB/E2F1 Signaling Pathway in Oxaliplatin-Resistant Colorectal Cancer Cells.

Yen-Pin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.